Teriminal partial AUC for Metformin ER Tablets [Regulatives / Guidelines]

posted by jag009  – NJ, 2014-09-11 22:07 (4304 d 13:04 ago) – Posting: # 13487
Views: 3,971

Hi,

Partial AUC assessment is for products with multiphasic drug delivery system (in USA, ie: Concerta, Ritalin LA, Adderall XR, Zolpidem). These products are designed to release drugs in two phases, an IR and an ER burst, for disease treatment strategies. Due to the clinical relevance of the drug release profile, partial AUCs are required to ensure that the generics yield similar drug exposures in the IR and ER portion of the profile relative to the innovator. importance As far as I know Metformin ER does not have such delivery system so Partial AUC is not really need. I ran metformin ER studies in the US and no partial AUCs were needed.

It seems like the EMA statement you quoted is a general statement and is not product specific.

John

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
137 visitors (0 registered, 137 guests [including 20 identified bots]).
Forum time: 11:12 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5